|
1
|
Punjabi NM: The epidemiology of adult
obstructive sleep apnea. Proc Am Thorac Soc. 5:136–143. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Casale M, et al: Obstructive sleep apnea
syndrome: from phenotype to genetic basis. Curr Genomics.
10:119–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Young T, Palta M, Dempsey J, Skatrud J,
Weber S and Badr S: The occurrence of sleep-disordered breathing
among middle-aged adults. N Engl J Med. 328:1230–1235. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tasali E and Ip MS: Obstructive sleep
apnea and metabolic syndrome: Alterations in glucose metabolism and
inflammation. Proc Am Thorac Soc. 5:207–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coughlin SR, Mawdsley L, Mugarza JA,
Calverley PM and Wilding JP: Obstructive sleep apnoea is
independently associated with an increased prevalence of metabolic
syndrome. Eur Heart J. 25:735–741. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ip MS, Lam B, Ng MM, Lam WK, Tsang KW and
Lam KS: Obstructive sleep apnea is independently associated with
insulin resistance. Am J Respir Crit Care Med. 165:670–676. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Punjabi NM, Shahar E, Redline S, Gottlieb
DJ, Givelber R and Resnick HE; Sleep Heart Health Study I.
Sleep-disordered breathing, glucose intolerance, and insulin
resistance: The sleep heart health study. Am J Epidemiol.
160:521–530. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goodson BL, Wung SF and Archbold KH:
Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: a
synergistic cardiovascular risk factor. J Am Acad Nurse Pract.
24:695–703. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao ZH, Yuan RY, Chen KY and Li GP:
Obstructive sleep apnea and the metabolic syndrome. Sleep Breath.
16:937–938. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Byberg S, Hansen AL, Christensen DL,
Vistisen D, Aadahl M, Linneberg A and Witte DR: Sleep duration and
sleep quality are associated differently with alterations of
glucose homeostasis. Diabet Med. 29:e354–e360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Cauter E: Sleep disturbances and
insulin resistance. Diabet Med. 28:1455–1462. 2011.PubMed/NCBI
|
|
12
|
Spiegel K, Knutson K, Leproult R, Tasali E
and Van Cauter E: Sleep loss: A novel risk factor for insulin
resistance and type 2 diabetes. J Appl Physiol. 99:2008–2019. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Finkel T, Deng CX and Mostoslavsky R:
Recent progress in the biology and physiology of sirtuins. Nature.
460:587–591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chakraborty C and Doss CG: Sirtuins
family-recent development as a drug target for aging, metabolism
and age related diseases. Curr Drug Targets. 14:666–675. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pucci B, Villanova L, Sansone L,
Pellegrini L, Tafani M, Carpi A, Fini M and Russo MA: Sirtuins: The
molecular basis of beneficial effects of physical activity. Intern
Emerg Med. 8(Suppl 1): S23–S25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bagul PK and Banerjee SK: Insulin
resistance, oxidative stress and cardiovascular complications: Role
of sirtuins. Curr Pharm Des. 19:5663–5677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YR, Lai YL, Lin SD, Li XT, Fu YC and
Xu WC: Sirt1 interacts with metabolic transcriptional factors in
the pancreas of insulin-resistant and calorie-restricted rats. Mol
Biol Rep. 40:3373–3380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung TW, Lee KT, Lee MW and Ka KH: Sirt1
attenuates palmitate-induced endoplasmic reticulum stress and
insulin resistance in hepg2 cells via induction of oxygen-regulated
protein 150. Biochem Biophys Res Commun. 422:229–232. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang RH, Kim HS, Xiao C, Xu X, Gavrilova O
and Deng CX: Hepatic sirt1 deficiency in mice impairs mtorc2/akt
signaling and results in hyperglycemia, oxidative damage and
insulin resistance. J Clin Invest. 121:4477–4490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baur JA, Pearson KJ, Price NL, Jamieson
HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K,
Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M,
Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D,
Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R and Sinclair
DA: Resveratrol improves health and survival of mice on a
high-calorie diet. Nature. 444:337–342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lagouge M, Argmann C, Gerhart-Hines Z,
Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P,
Elliott P, Geny B, Laakso M, Puigserver P and Auwerx J: Resveratrol
improves mitochondrial function and protects against metabolic
disease by activating sirt1 and pgc-1alpha. Cell. 127:1109–1122.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tennen RI, Michishita-Kioi E and Chua KF:
Finding a target for resveratrol. Cell. 148:387–389. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gertz M, Nguyen GT, Fischer F, Suenkel B,
Schlicker C, Franzel B, Tomaschewski J, Aladini F, Becker C,
Wolters D and Steegborn C: A molecular mechanism for direct sirtuin
activation by resveratrol. PloS One. 7:e497612012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iiyori N, Alonso LC, Li J, Sanders MH,
Garcia-Ocana A, O’Doherty RM, Polotsky VY and O’Donnell CP:
Intermittent hypoxia causes insulin resistance in lean mice
independent of autonomic activity. Am J Respir Crit Care Med.
175:851–857. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Polotsky VY, Rubin AE, Balbir A, Dean T,
Smith PL, Schwartz AR and O’Donnell CP: Intermittent hypoxia causes
rem sleep deficits and decreases eeg delta power in nrem sleep in
the c57bl/6j mouse. Sleep Med. 7:7–16. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi K and Kim YB: Molecular mechanism of
insulin resistance in obesity and type 2 diabetes. Korean J Intern
Med. 25:119–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Babacanoglu C, Yildirim N, Sadi G, Pektas
MB and Akar F: Resveratrol prevents high-fructose corn
syrup-induced vascular insulin resistance and dysfunction in rats.
Food Chem Toxicol. 60:160–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng AS, Cheng YH, Chiou CH and Chang TL:
Resveratrol upregulates nrf2 expression to attenuate
methylglyoxal-induced insulin resistance in hep g2 cells. J Agric
Food Chem. 60:9180–9187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bagul PK, Middela H, Matapally S, Padiya
R, Bastia T, Madhusudana K, Reddy BR, Chakravarty S and Banerjee
SK: Attenuation of insulin resistance, metabolic syndrome and
hepatic oxidative stress by resveratrol in fructose-fed rats.
Pharmacol Res. 66:260–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen S, Li J, Zhang Z, Li W, Sun Y, Zhang
Q, Feng X and Zhu W: Effects of resveratrol on the amelioration of
insulin resistance in kkay mice. Can J Physiol Pharmacol.
90:237–242. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng J, Chen LL, Zhang HH, Hu X, Kong W
and Hu D: Resveratrol improves insulin resistance of catch-up
growth by increasing mitochondrial complexes and antioxidant
function in skeletal muscle. Metabolism. 61:954–965. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen LL, Zhang HH, Zheng J, Hu X, Kong W,
Hu D, Wang SX and Zhang P: Resveratrol attenuates high-fat
diet-induced insulin resistance by influencing skeletal muscle
lipid transport and subsarcolemmal mitochondrial beta-oxidation.
Metabolism. 60:1598–1609. 2011. View Article : Google Scholar
|
|
33
|
Labbé A, Garand C, Cogger VC, Paquet ER,
Desbiens M, Le Couteur DG and Lebel M: Resveratrol improves insulin
resistance hyperglycemia and hepatosteatosis but not
hypertriglyceridemia, inflammation and life span in a mouse model
for Werner syndrome. J Gerontol A Biol Sci Med Sci. 66:264–278.
2011.PubMed/NCBI
|
|
34
|
Howitz KT, Bitterman KJ, Cohen HY, Lamming
DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL,
Scherer B and Sinclair DA: Small molecule activators of sirtuins
extend Saccharomyces cerevisiae lifespan. Nature.
425:191–196. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yun JM, Chien A, Jialal I and Devaraj S:
Resveratrol up-regulates sirt1 and inhibits cellular oxidative
stress in the diabetic milieu: Mechanistic insights. J Nutr
Biochem. 23:699–705. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang F, Kume S and Koya D: Sirt1 and
insulin resistance. Nat Rev Endocrinol. 5:367–373. 2009. View Article : Google Scholar
|
|
37
|
Zabolotny JM and Kim YB: Silencing insulin
resistance through sirt1. Cell Metab. 6:247–249. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Farese RV, Sajan MP and Standaert ML:
Insulin-sensitive protein kinases (atypical protein kinase c and
protein kinase b/akt): Actions and defects in obesity and type II
diabetes. Exp Biol Med (Maywood). 230:593–605. 2005.PubMed/NCBI
|
|
39
|
Cheatham B, Vlahos CJ, Cheatham L, Wang L,
Blenis J and Kahn CR: Phosphatidylinositol 3-kinase activation is
required for insulin stimulation of pp70 s6 kinase, DNA synthesis
and glucose transporter translocation. Mol Cell Biol. 14:4902–4911.
1994.
|
|
40
|
Kim YB, Nikoulina SE, Ciaraldi TP, Henry
RR and Kahn BB: Normal insulin-dependent activation of akt/protein
kinase b, with diminished activation of phosphoinositide 3-kinase,
in muscle in type 2 diabetes. J Clin Invest. 104:733–741. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bjornholm M, Kawano Y, Lehtihet M and
Zierath JR: Insulin receptor substrate-1 phosphorylation and
phosphatidylinositol 3-kinase activity in skeletal muscle from
niddm subjects after in vivo insulin stimulation. Diabetes.
46:524–527. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Frojdo S, Durand C, Molin L, Carey AL,
El-Osta A, Kingwell BA, Febbraio MA, Solari F, Vidal H and Pirola
L: Phosphoinositide 3-kinase as a novel functional target for the
regulation of the insulin signaling pathway by sirt1. Mol Cell
Endocrinol. 335:166–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
